Articles related to BONE HEALTH

Comprehensive data package, including structural and functional analytical data, clinical pharmacokinetic data, and a comparative clinical study demonstrating that Bildyos and Bilprevda are highly similar to and have no clinically meaningful differences from their reference products.

Clinical practice observations of AVN following hip injury where non-adherence to activity restrictions was a contributing factor highlight the intersection of medication effects and behavioral challenges in ADHD patients.

The balance between bone breakdown and formation becomes disrupted with aging, with postmenopausal women experiencing accelerated bone loss of 2-3% annually before stabilizing, making targeted intervention during this critical window essential for preventing fractures.

Women consuming moderate liquid dairy showed 23-26% reduction in fracture risk, while cheese intake specifically reduced hip fractures by 47%, suggesting distinct protective mechanisms for different bone sites.

Joint and muscle pain are established side effects across multiple medication classes including antibiotics, cholesterol-lowering agents, and cancer therapies, with varying onset timing, risk factors, and management approaches that clinicians should recognize to optimize treatment adherence.

Clinical trials reveal that osteoporosis screening is associated with five to six fewer fractures per 1,000 participants compared to usual care, providing concrete evidence for screening’s clinical value.